isomethyleugenol has been researched along with irinotecan in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, Y; Guan, W; Liu, B; Qian, X; Shen, J; Wang, H; Wei, J; Xie, L; Yang, Y; Yu, L; Yue, G; Zou, Z | 1 |
Fan, WF; Liu, BR; Meng, LJ; Shen, J; Wang, J; Wang, L | 1 |
Bähr, O; Belka, C; Braun, C; Gerlach, R; Glas, M; Goldbrunner, R; Hänel, M; Hattingen, E; Hau, P; Herrlinger, U; Junold, N; Kebir, S; Kortmann, RD; Krex, D; Mack, F; Niessen, M; Proescholdt, M; Rohde, V; Sabel, M; Schäfer, N; Schaub, C; Schlegel, U; Schmidt-Graf, F; Steinbach, JP; Stuplich, M; Tzaridis, T; Vatter, H; Weyerbrock, A | 1 |
Sartore-Bianchi, A; Siena, S | 1 |
1 trial(s) available for isomethyleugenol and irinotecan
Article | Year |
---|---|
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cell Growth Processes; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy; Temozolomide; Tumor Suppressor Proteins | 2018 |
3 other study(ies) available for isomethyleugenol and irinotecan
Article | Year |
---|---|
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers, Tumor; Camptothecin; Drug Screening Assays, Antitumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Male; Methylation; Mice; Middle Aged; Models, Genetic; Neoplasm Proteins; Reproducibility of Results; Stomach Neoplasms; Sulfatases; Sulfotransferases; Xenograft Model Antitumor Assays | 2013 |
[Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; DNA Methylation; Exodeoxyribonucleases; Humans; Irinotecan; Methylation; Promoter Regions, Genetic; RecQ Helicases; Stomach Neoplasms; Sulfatases; Sulfotransferases; Werner Syndrome Helicase | 2013 |
The right chance for temozolomide in metastatic colorectal cancer?
Topics: Colorectal Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Humans; Irinotecan; Methylation; Salvage Therapy; Temozolomide; Tumor Suppressor Proteins | 2018 |